Beta Bionics, Inc. (BBNX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 26.02M USD | Liabilities, Current |
| Cash and equivalents | 44.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 18.05M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 23.92M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $26.02M | $44.32M | (m) | $18.05M | $23.92M | (m) |
| 2026-03-31 | (m) | $23.19M | $30.21M | (m) | $15.75M | $23.73M | (m) |
| 2025-12-31 | (m) | $30.92M | $31.58M | (m) | $17.12M | $21.72M | (m) |
| 2025-09-30 | (m) | $25.39M | $38.48M | (m) | $11.54M | $20.37M | (m) |
| 2025-06-30 | (m) | $19.49M | $35.08M | (m) | $11.39M | $17.32M | (m) |
| 2025-03-31 | (m) | $16.49M | $42.45M | (m) | $9.06M | $15.73M | (m) |
| 2024-12-31 | (m) | $21.15M | $30.43M | (m) | $12.00M | $13.32M | (m) |
| 2024-09-30 | (m) | (m) | $17.48M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $13.03M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | $22.07M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $10.61M | $26.57M | (m) | $4.45M | $1.25M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |